Assessing the need for cardioverter defibrillator implantation in hypertrophic cardiomyopathy: patient association's perspectives
Eur Heart J
.
2026 Jun 26:ehag412.
doi: 10.1093/eurheartj/ehag412.
Online ahead of print.
Authors
Niccolò Maurizi
1
2
3
,
Iacopo Olivotto
1
4
5
,
Franco Cecchi
3
Affiliations
1
Cardiomyopathy Unit, Careggi University Hospital, Largo Bramibilla 3, Florence 50121, Italy.
2
Service of Cardiology, Lausanne University Hospita, 1011 Lausanne, Switzerland.
3
AICARM APS, Via Livorno 54/3, 50142 Florence, Italy.
4
Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
5
Service of Cardiology, Meyer Children's Hospital IRCCS, Florence, Italy.
PMID:
42360856
DOI:
10.1093/eurheartj/ehag412
No abstract available
Grants and funding
Bristol Meier Squibb
Cytokinetics
Amicus
Genzyme
Shire
Bayer
Boston Scientific
Menarini International
Foundation CVCL
Bangarter-Rhyner Foundation
Guidepoint